PL2391381T3 - Zastosowanie synergicznego połączenia jonów podtiocyjanowych i/lub podhalogenawych, i lektoferyny do wytwarzania leku na mukowiscydozę - Google Patents
Zastosowanie synergicznego połączenia jonów podtiocyjanowych i/lub podhalogenawych, i lektoferyny do wytwarzania leku na mukowiscydozęInfo
- Publication number
- PL2391381T3 PL2391381T3 PL10707062T PL10707062T PL2391381T3 PL 2391381 T3 PL2391381 T3 PL 2391381T3 PL 10707062 T PL10707062 T PL 10707062T PL 10707062 T PL10707062 T PL 10707062T PL 2391381 T3 PL2391381 T3 PL 2391381T3
- Authority
- PL
- Poland
- Prior art keywords
- hypothiocyanite
- lactoferrin
- preparing
- treatment
- cystic fibrosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0950536A FR2941374B1 (fr) | 2009-01-28 | 2009-01-28 | Utilisation d'une association synergique d'ions hypothiocyanites et/ou hypohalites et de lactoferrine pour la preparation pour le traitement de la mucoviscidose |
EP10707062.5A EP2391381B1 (fr) | 2009-01-28 | 2010-01-28 | Utilisation d'une association synergique d'ions hypothiocyanites et/ou hypohalites et de lactoferrine pour la préparation pour le traitement de la mucoviscidose |
PCT/FR2010/000070 WO2010086530A1 (fr) | 2009-01-28 | 2010-01-28 | Utilisation d'une association synergique d'ions hypothiocyanites et/ou hypohalites et de lactoferrine pour la préparation pour le traitement de la mucoviscidose |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2391381T3 true PL2391381T3 (pl) | 2016-02-29 |
Family
ID=40792836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10707062T PL2391381T3 (pl) | 2009-01-28 | 2010-01-28 | Zastosowanie synergicznego połączenia jonów podtiocyjanowych i/lub podhalogenawych, i lektoferyny do wytwarzania leku na mukowiscydozę |
Country Status (9)
Country | Link |
---|---|
US (1) | US9078859B2 (pl) |
EP (1) | EP2391381B1 (pl) |
AU (1) | AU2010209593B2 (pl) |
CA (1) | CA2750696C (pl) |
ES (1) | ES2555055T3 (pl) |
FR (1) | FR2941374B1 (pl) |
NZ (1) | NZ594344A (pl) |
PL (1) | PL2391381T3 (pl) |
WO (1) | WO2010086530A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2980974B1 (fr) * | 2011-10-10 | 2014-02-21 | Alaxia | Composition comprenant un sel d'hypothiocyanite d'un cation alcalin, a l'etat solide |
CA2925546C (en) | 2012-10-29 | 2022-06-14 | The University Of North Carolina At Chapel Hill | Methods and compositions for treating mucosal tissue disorders |
EP2799068A1 (en) | 2013-05-01 | 2014-11-05 | National University of Ireland, Galway | Antimicrobial compositions and methods for their production |
EP3541401A4 (en) | 2016-11-17 | 2020-07-29 | Renovion, Inc. | TREATMENT OF AIRWAY DISEASES AND INFECTIONS WITH GLUTATHION COMPOSITIONS |
SG11202004540QA (en) | 2017-11-17 | 2020-06-29 | Renovion Inc | Stable ascorbic acid compositions and methods of using the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61701B1 (en) * | 1986-07-17 | 1994-11-30 | Morinaga Milk Industry Co Ltd | Process for producing bovine lactoferrin in high purity |
US6702998B2 (en) | 2001-05-15 | 2004-03-09 | Gregory E. Conner | Methods and devices for treating lung dysfunction |
US20060073212A1 (en) * | 2004-04-22 | 2006-04-06 | Palmer Craig R | Method of treating respiratory disorders and airway inflammation |
AU2007249348C1 (en) * | 2006-05-10 | 2013-01-17 | Laclede, Inc. | Compositions and methods for enzymatic treatment of lung disorders |
WO2008003688A1 (en) * | 2006-07-03 | 2008-01-10 | Jean-Paul Perraudin | Antimicrobial composition and uses thereof |
NZ583234A (en) * | 2007-07-10 | 2012-06-29 | Glanbia Nutritionals | Method for removing endotoxin from proteins |
-
2009
- 2009-01-28 FR FR0950536A patent/FR2941374B1/fr not_active Expired - Fee Related
-
2010
- 2010-01-28 AU AU2010209593A patent/AU2010209593B2/en not_active Ceased
- 2010-01-28 ES ES10707062.5T patent/ES2555055T3/es active Active
- 2010-01-28 US US13/146,779 patent/US9078859B2/en not_active Expired - Fee Related
- 2010-01-28 WO PCT/FR2010/000070 patent/WO2010086530A1/fr active Application Filing
- 2010-01-28 NZ NZ59434410A patent/NZ594344A/xx not_active IP Right Cessation
- 2010-01-28 PL PL10707062T patent/PL2391381T3/pl unknown
- 2010-01-28 EP EP10707062.5A patent/EP2391381B1/fr not_active Not-in-force
- 2010-01-28 CA CA2750696A patent/CA2750696C/fr active Active
Also Published As
Publication number | Publication date |
---|---|
AU2010209593A1 (en) | 2011-08-18 |
US9078859B2 (en) | 2015-07-14 |
FR2941374B1 (fr) | 2011-03-11 |
NZ594344A (en) | 2013-03-28 |
EP2391381A1 (fr) | 2011-12-07 |
ES2555055T3 (es) | 2015-12-28 |
AU2010209593B2 (en) | 2014-10-30 |
CA2750696C (fr) | 2016-01-19 |
FR2941374A1 (fr) | 2010-07-30 |
WO2010086530A1 (fr) | 2010-08-05 |
US20120021071A1 (en) | 2012-01-26 |
CA2750696A1 (fr) | 2010-08-05 |
EP2391381B1 (fr) | 2015-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212892A1 (zh) | 用於治療囊性纖維化的單獨和與 抑制劑組合的 刺激劑或 激活劑 | |
HK1165293A1 (en) | Composition for the treatment of cystic fibrosis | |
PT2564698T (pt) | Combinações de substâncias ativas nematicidas, compreendendo fluopiram e bacillus firmus | |
EP2478884A4 (en) | MASSAGE BRUSH AND HANDLE FOR MASSAGE BRUSH | |
EP2224924A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS | |
ZA201106930B (en) | Synergistic combinations of active ingredients | |
EP2249854A4 (en) | IMPROVED TREATMENT AND PROPHYLAXIS | |
PL2303022T3 (pl) | Synergiczne połączenie chwastobójcze chlomazonu i petoksamidu | |
EP2069795A4 (en) | SYNERGISTIC TREATMENT OF EPHA2 AND ERBB2 EXPRESSIVE CELLS | |
EP2482814A4 (en) | METHOD AND COMPOSITIONS FOR TREATING OKULAR FIBROSIS | |
IL217292A0 (en) | Polypeptides and method of treatment | |
GB0919097D0 (en) | Treatment of hard surfaces | |
IL220661A0 (en) | Beta-carbolines for use in the treatment of hearing loss and vertigo | |
PL2391381T3 (pl) | Zastosowanie synergicznego połączenia jonów podtiocyjanowych i/lub podhalogenawych, i lektoferyny do wytwarzania leku na mukowiscydozę | |
EP1986952A4 (en) | METHOD FOR THE TREATMENT OF MUCOVISCIDOSIS | |
ZA201202434B (en) | Use of aerosolized levofloxacin for treating cystic fibrosis | |
GB0619500D0 (en) | Treatment of fibrosis | |
HK1173949A1 (en) | Glp-2 for use in the treatment of muscle atrophy glp-2 | |
AP3650A (en) | Apolipoprotein l-i variants and their use | |
HK1165271A1 (en) | Composition comprising vip or its active fragments for use in treating aortic fibrosis | |
IL217722A0 (en) | Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans | |
PL2833891T3 (pl) | Kompozycja do leczenia mukowiscydozy i do indukcji wydzielania jonów | |
IL220241A0 (en) | Use of transferrin in treatment of beta-thalassemias | |
EP2424535A4 (en) | METHODS AND COMPOSITIONS FOR TREATING DRY EYE | |
GB201000571D0 (en) | Treatment of cystic fibrosis |